ovel maintenance Immunosuppression with Controlled systemic Exposure

Completed

• Conditions: Renal transplant; Surgery; Transplanted organ and tissue status

• Registration Number: ISRCTN81895822
• Lead Sponsor: eiden University Medical Center (LUMC) (Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2006-01-27
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

1. Patients, 18 years or older, on maintenance therapy with cyclosporin, MMF and steroids
2. Informed consent

Exclusion Criteria

1. Calculated creatinine clearance 20 ml/min
2. Multi-organ recipients
3. Patients with an (historic) PRA >60%
4. Vascular type rejection in the past
5. Patients with more than two acute rejection episodes in the past
6. Third renal transplant or more
7. Patients receiving other investigational drugs than MMF in combination with Neoral
8. Metastatic neoplasms, post-transplant lymphoproliferative disease

Study & Design

• Study Type: Interventional
• Study Design: Not specified